Quick Takeaways
- AVADEL PHARMACEUTICALS PLC has 13 insiders with reported activity on this page.
- Net insider value flow over the last year: -$233,353,092.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 13 Insiders of AVADEL PHARMACEUTICALS PLC
- Location
- Dublin 2
What Changed
- Buy value: ; sell value: $233,353,092.
- Net share flow: -11,112,052.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$233,353,092.
Buys
$0
Shares: 0
Insiders: 0
Sells
$233,353,092
Shares: 11,112,052
Insiders: 1
Net
-$233,353,092
Shares: -11,112,052
Insiders: -1
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 11,112,052 | $0 | $233,353,092 | -$233,353,092 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
AVADEL PHARMACEUTICALS PLC executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Geoffrey Michael Glass | Director | $140,250 | Mixed | 12 Feb 2026 | ||
| Linda Palczuk | Director | $140,250 | Mixed | 12 Feb 2026 | ||
| Gregory J. Divis | Chief Executive Officer, Director | $0 | Mixed | 12 Feb 2026 | ||
| Naseem Amin | Director | $0 | Mixed | 12 Feb 2026 | ||
| Jerad G. Seurer | Gen. Counsel & Corp. Secretary | $0 | Mixed | 12 Feb 2026 | ||
| Thomas S. Mchugh | Chief Financial Officer | $0 | Mixed | 12 Feb 2026 | ||
| Mark Anthony McCamish | Director | $0 | Mixed | 12 Feb 2026 | ||
| Peter J. Thornton | Director | $0 | Mixed | 12 Feb 2026 | ||
| Weiss Asset Management LP | Former 10% Owner | $0 | -$233,353,092 | -100% | Mixed | 13 Feb 2026 |
| Eric J. Ende | Director | $0 | Mixed | 12 Feb 2026 | ||
| Susan Rodriguez | Chief Operating Officer | Mixed | 12 Feb 2026 | |||
| Douglas J. Williamson | Chief Medical Officer | Mixed | 14 Feb 2022 | |||
| Richard J. Kim | Chief Commercial Officer | Mixed | 20 Feb 2024 |
Top shareholders of AVADEL PHARMACEUTICALS PLC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
7%
from 13D/G
|
7,041,102
|
$151,735,747 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
5.7%
from 13D/G
|
5,864,781
|
$126,386,030 | — | 31 Dec 2025 | |
| Jeffrey L. Gendell |
13F
13D/G
|
Individual |
4.9%
from 13D/G
|
4,769,357
|
$102,779,643 | — | 31 Dec 2025 | |
| Weiss Asset Management LP |
13F
|
Company |
4.7%
|
4,515,114
|
$97,300,707 | — | 31 Dec 2025 | |
| TIG Advisors, LLC |
13F
|
Company |
4%
|
3,859,122
|
$83,164,079 | — | 31 Dec 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
3.1%
|
2,983,541
|
$64,295,309 | — | 31 Dec 2025 | |
| FIL Ltd |
13F
|
Company |
2.9%
|
2,822,777
|
$60,830,844 | — | 31 Dec 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
2.8%
|
2,684,109
|
$57,842,549 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
2,278,301
|
$49,097,387 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,156,356
|
$46,477,231 | — | 31 Dec 2025 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.1%
|
2,048,585
|
$44,147,007 | — | 31 Dec 2025 | |
| WEALTH EFFECTS LLC |
13F
|
Company |
2%
|
1,891,917
|
$40,770,806 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
13D/G
|
Company |
1.9%
from 13D/G
|
1,823,865
|
$39,300,130 | — | 31 Dec 2025 | |
| Pentwater Capital Management LP |
13F
|
Company |
1.8%
|
1,684,000
|
$36,290,200 | — | 31 Dec 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
1,194,197
|
$25,734,945 | — | 31 Dec 2025 | |
| WATER ISLAND CAPITAL LLC |
13F
|
Company |
1.1%
|
1,087,117
|
$23,427,370 | — | 31 Dec 2025 | |
| Krensavage Asset Management, LLC |
13F
|
Company |
0.89%
|
855,860
|
$18,444,000 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.83%
|
797,200
|
$17,179,660 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.83%
|
793,752
|
$17,105,356 | — | 31 Dec 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.81%
|
782,239
|
$16,857,250 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.8%
|
770,232
|
$16,598,500 | — | 31 Dec 2025 | |
| Kevin Kotler |
13F
|
Individual |
0.77%
|
741,343
|
$15,975,942 | — | 31 Dec 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.73%
|
702,066
|
$15,129,522 | — | 31 Dec 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.71%
|
684,321
|
$14,747,117 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.68%
|
655,058
|
$14,116,500 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.63%
|
607,268
|
$13,086,625 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.63%
|
606,106
|
$13,061,583 | — | 31 Dec 2025 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.61%
|
600,000
|
$12,930,000 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.61%
|
585,102
|
$12,608,948 | — | 31 Dec 2025 | |
| Modera Wealth Management, LLC |
13F
|
Company |
0.58%
|
558,972
|
$12,045,847 | — | 31 Dec 2025 | |
| Caption Management, LLC |
13F
|
Company |
0.56%
|
536,838
|
$11,568,859 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.55%
|
529,074
|
$11,401,549 | — | 31 Dec 2025 | |
| ALPINE ASSOCIATES MANAGEMENT INC. |
13F
|
Company |
0.55%
|
525,550
|
$11,325,603 | — | 31 Dec 2025 | |
| CREDIT INDUSTRIEL ET COMMERCIAL |
13F
|
Individual |
0.54%
|
522,034
|
$11,249,833 | — | 31 Dec 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.54%
|
513,928
|
$11,075,148 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.52%
|
500,561
|
$10,787,090 | — | 31 Dec 2025 | |
| Groupe la Francaise |
13F
|
Individual |
0.5%
|
479,291
|
$10,328,721 | — | 31 Dec 2025 | |
| Verition Fund Management LLC |
13F
|
Company |
0.47%
|
450,981
|
$9,718,641 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.44%
|
420,072
|
$9,052,552 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.37%
|
351,924
|
$7,583,962 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.36%
|
344,933
|
$7,433,306 | — | 31 Dec 2025 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.35%
|
337,481
|
$7,272,716 | — | 31 Dec 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.33%
|
316,189
|
$6,813,873 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.31%
|
300,677
|
$6,479,589 | — | 31 Dec 2025 | |
| HARVEST MANAGEMENT LLC |
13F
|
Company |
0.31%
|
300,000
|
$6,465,000 | — | 31 Dec 2025 | |
| GABELLI & Co INVESTMENT ADVISERS, INC. |
13F
|
Company |
0.31%
|
297,566
|
$6,412,547 | — | 31 Dec 2025 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.3%
|
283,734
|
$6,114,468 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.29%
|
279,525
|
$6,023,764 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.29%
|
273,600
|
$5,896,080 | — | 31 Dec 2025 | |
| WEXFORD CAPITAL LP |
13F
|
Company |
0.28%
|
272,821
|
$5,879,290 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for AVADEL PHARMACEUTICALS PLC
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Weiss Asset Management LP | AVDL | Ordinary Shares | Sale | -100% | $233,353,092 | $21.00 | -11,112,052 | 0 | 13 Feb 2026 | See Footnote 2 |
| Susan Rodriguez | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -300,000 | 0 | 12 Feb 2026 | Direct | ||
| Peter J. Thornton | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -115,060 | 0 | 12 Feb 2026 | Direct | ||
| Peter J. Thornton | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -241,000 | 0 | 12 Feb 2026 | Direct | ||
| Jerad G. Seurer | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -23,496 | 0 | 12 Feb 2026 | Direct | ||
| Jerad G. Seurer | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -491,500 | 0 | 12 Feb 2026 | Direct | ||
| Linda Palczuk | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -78,905 | 0 | 12 Feb 2026 | Direct | ||
| Linda Palczuk | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -266,000 | 0 | 12 Feb 2026 | By Trust | ||
| Thomas S. Mchugh | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -100,400 | 0 | 12 Feb 2026 | Direct | ||
| Thomas S. Mchugh | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -1,004,500 | 0 | 12 Feb 2026 | Direct | ||
| Mark Anthony McCamish | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -67,025 | 0 | 12 Feb 2026 | By McCamish Charitable Remainder Trust | ||
| Mark Anthony McCamish | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -22,000 | 0 | 12 Feb 2026 | Direct | ||
| Mark Anthony McCamish | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -291,000 | 0 | 12 Feb 2026 | Direct | ||
| Geoffrey Michael Glass | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -144,979 | 0 | 12 Feb 2026 | By Trust | ||
| Geoffrey Michael Glass | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -22,005 | 0 | 12 Feb 2026 | Direct | ||
| Geoffrey Michael Glass | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -241,000 | 0 | 12 Feb 2026 | By Trust | ||
| Eric J. Ende | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -219,905 | 0 | 12 Feb 2026 | Direct | ||
| Eric J. Ende | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -249,057 | 0 | 12 Feb 2026 | Direct | ||
| Gregory J. Divis | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -10,000 | 0 | 12 Feb 2026 | By Trust | ||
| Gregory J. Divis | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -211,105 | 0 | 12 Feb 2026 | Direct | ||
| Gregory J. Divis | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -2,870,000 | 0 | 12 Feb 2026 | Direct | ||
| Naseem Amin | AVDL | Ordinary Shares | Disposed to Issuer | -100% | -22,000 | 0 | 12 Feb 2026 | Direct | ||
| Naseem Amin | AVDL | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -71,500 | 0 | 12 Feb 2026 | Direct | ||
| Mark Anthony McCamish | AVDL | Ordinary Shares | Gift | 67,025 | 67,025 | 04 Feb 2026 | By McCamish Charitable Remainder Trust | |||
| Mark Anthony McCamish | AVDL | Ordinary Shares | Gift | -100% | -67,025 | 0 | 04 Feb 2026 | By Matthew 5 LLC | ||
| Linda Palczuk | AVDL | Stock Option (Right to Buy) | Gift | -100% | -11,000 | 0 | 15 Sep 2025 | Direct | ||
| Geoffrey Michael Glass | AVDL | Stock Option (Right to Buy) | Gift | -100% | -11,000 | 0 | 15 Sep 2025 | Direct | ||
| Mark Anthony McCamish | AVDL | Ordinary Shares | Award | 100% | 11,000 | 22,000 | 29 Jul 2025 | Direct | ||
| Mark Anthony McCamish | AVDL | Stock Option (Right to Buy) | Award | 11,000 | 11,000 | 29 Jul 2025 | Direct | |||
| Linda Palczuk | AVDL | Ordinary Shares | Award | 16.2% | 11,000 | 78,900 | 29 Jul 2025 | Direct | ||
| Linda Palczuk | AVDL | Stock Option (Right to Buy) | Award | 11,000 | 11,000 | 29 Jul 2025 | Direct | |||
| Peter J. Thornton | AVDL | Ordinary Shares | Award | 10.6% | 11,000 | 115,055 | 29 Jul 2025 | Direct | ||
| Peter J. Thornton | AVDL | Stock Option (Right to Buy) | Award | 11,000 | 11,000 | 29 Jul 2025 | Direct | |||
| Geoffrey Michael Glass | AVDL | Ordinary Shares | Award | 100% | 11,000 | 22,000 | 29 Jul 2025 | Direct | ||
| Geoffrey Michael Glass | AVDL | Stock Option (Right to Buy) | Award | 11,000 | 11,000 | 29 Jul 2025 | Direct | |||
| Eric J. Ende | AVDL | Ordinary Shares | Award | 5.27% | 11,000 | 219,900 | 29 Jul 2025 | Direct | ||
| Eric J. Ende | AVDL | Stock Option (Right to Buy) | Award | 11,000 | 11,000 | 29 Jul 2025 | Direct | |||
| Naseem Amin | AVDL | Ordinary Shares | Award | 100% | 11,000 | 22,000 | 29 Jul 2025 | Direct | ||
| Naseem Amin | AVDL | Stock Option (Right to Buy) | Award | 11,000 | 11,000 | 29 Jul 2025 | Direct | |||
| Susan Rodriguez | AVDL | Stock Option (Right to Buy) | Award | 300,000 | 300,000 | 13 May 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.